Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,889,749 | 2,263,384 | 1,561,221 | 852,094 | 2,625,592 |
| Depreciation Amortization | 265,477 | 187,960 | 118,907 | 60,106 | 212,944 |
| Income taxes - deferred | 12,152 | 42,720 | 29,896 | 31,060 | -42,013 |
| Accounts receivable | -348,875 | -352,081 | -242,381 | -163,914 | -356,462 |
| Accounts payable and accrued liabilities | -4,453 | 141,692 | 262,262 | 141,727 | 203,641 |
| Other Working Capital | -680,380 | -513,361 | -440,980 | -323,838 | 30,209 |
| Other Operating Activity | 700,243 | 338,756 | 80,723 | 73,334 | 406,143 |
| Operating Cash Flow | $2,833,913 | $2,109,070 | $1,369,648 | $670,569 | $3,080,054 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,784,867 | -1,400,412 | -108,089 | -1,057,112 | -738,027 |
| PPE Investments | -61,884 | -38,523 | -27,717 | -11,666 | -230,057 |
| Net Acquisitions | -91,000 | -91,000 | N/A | N/A | -1,247,816 |
| Investing Cash Flow | $-1,937,751 | $-1,529,935 | $-135,806 | $-1,068,778 | $-2,215,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,962,500 | 2,962,500 | 500,000 | 0 | 400,000 |
| Debt Repayment | -868,408 | -868,211 | -5,556 | -19 | -711,103 |
| Common Stock Issued | 376,648 | 322,251 | 144,291 | 103,362 | 222,728 |
| Common Stock Repurchased | -4,022,593 | -3,407,055 | -1,854,081 | -162,520 | -998,495 |
| Other Financing Activity | 213,143 | 111,461 | 65,842 | 75,209 | 35,432 |
| Financing Cash Flow | $-1,338,710 | $-879,054 | $-1,149,504 | $16,032 | $-1,051,438 |
| Exchange Rate Effect | 77,469 | 49,954 | 125,343 | 46,099 | 940 |
| Beginning Cash Position | 1,272,958 | 1,272,958 | 1,272,958 | 1,272,958 | 1,459,302 |
| End Cash Position | 907,879 | 1,022,993 | 1,482,639 | 936,880 | 1,272,958 |
| Net Cash Flow | $-365,079 | $-249,965 | $209,681 | $-336,078 | $-186,344 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,833,913 | 2,109,070 | 1,369,648 | 670,569 | 3,080,054 |
| Capital Expenditure | -61,884 | -38,523 | -27,717 | -11,666 | -230,057 |
| Free Cash Flow | 2,772,029 | 2,070,547 | 1,341,931 | 658,903 | 2,849,997 |